Related by context. All words. (Click for frequent words.) 65 Vitro Diagnostic Multivariate 64 T SPOT.TB 63 Risk Stratification 63 HOXB# 62 RT qPCR 62 Diastolic Heart Failure 62 vitro diagnostic multivariate 62 immunohistochemical 62 Histologic 62 interobserver 62 Immunohistochemical 61 Reproducibility 61 MammaPrint R 61 IVDMIA 61 Histological 61 Antigen CEA 61 gastric carcinoma 61 clinicopathological 61 #F FDG PET 61 Estrogen Receptor 61 molecular diagnostic assay 60 Quantitative PCR 60 VerifyNow 60 multiplex assay 60 qRT PCR 60 Oncotype 60 QT Prolongation 60 Corus CAD 60 NMP# BladderChek 59 Homeostasis 59 FDG-PET/CT 59 Echocardiographic 59 Crystallographic 59 FDG PET imaging 59 bronchoalveolar lavage 59 FISH fluorescence 59 Septin9 59 microdose 59 microRNA profiling 59 CellSearch ™ 59 STRIDE PD 59 immunochemical fecal occult 59 Ki# 59 VeriStrat 59 ImmunoCAP ® 59 Histopathological 59 DNA methylation markers 59 VerifyNow P#Y# 59 prognostic biomarker 59 Apoptotic 58 pretransplant 58 RQ PCR 58 Prognostic 58 Vitro Diagnostic 58 flow cytometric 58 ELISPOT 58 Erythropoietic 58 Radient Pharmaceutical current 58 miRview squamous 58 diagnostic modality 58 NICE SUGAR 58 Lymph node 58 CupPrint R 58 thyroglobulin 58 HER2 expression 58 Prognostic Index 58 Quantitation 58 IntroductionThe 58 clinicopathologic 58 gene methylation 58 miRview meso 58 bone scintigraphy 58 Clinical Validation 58 immunohistochemical analysis 58 Pharmacogenetic 58 Confirmatory 58 p# antigen 58 EarlyCDT Lung 58 powder diffraction 58 Fractional Flow Reserve 58 carcinoembryonic antigen 58 cTnI 58 Activity Assay 58 ImmuKnow R 57 endoscopic ultrasonography 57 NuroPro PD 57 Cardiotoxicity 57 MALDI TOF MS 57 NIR spectroscopy 57 murine models 57 prostate carcinoma 57 SF #v# 57 clinico pathological 57 transcriptomic 57 sDNA 57 NSCLC tumors 57 immunoblot 57 Deforolimus 57 Sanger Sequencing 57 Serological 57 biodistribution studies 57 eNO 57 SPECT CT imaging 57 UGT#A# 57 hc2 57 immunofluorescent 57 nodal metastasis 57 Genotypic 57 Capillary Electrophoresis 57 HLA genotyping 57 cardiac troponin 57 CyPath ® 57 intraobserver 57 HemeScan 57 mediated inhibition 57 aminotransferase 57 Lp PLA 2 57 prostate cancer PCa 57 Vitro Diagnostic Cancer 57 urothelial carcinoma 57 Pathwork Tissue 57 metastatic malignant 57 APTIMA HPV 57 KRAS mutation 57 immunocytochemistry 57 cytologic 57 platelet reactivity 57 pT2 57 RECIST Response Evaluation Criteria 57 BRAF V#E mutation 57 Flow cytometry 57 diagnostic biomarker 57 PGxPredict 57 retest reliability 57 F FDG PET 57 haematologic 57 Amplicor 57 miRview TM mets 56 Clinical Relevance 56 NMP# 56 TMPRSS2 ERG 56 thyroid carcinoma 56 Temsirolimus 56 radioimmunotherapy RIT 56 Clusterin 56 ERK signaling 56 SIR Spheres 56 ImmuKnow 56 Electrophysiological 56 chemosensitivity 56 TNM staging 56 Epigenomics proprietary 56 Oncotype DX Recurrence Score 56 Upregulation 56 histopathological 56 Xelox 56 HepaSphere 56 GeneSightRx 56 Pharmacodynamic 56 histopathologic 56 Salivary 56 CaPSURE 56 miRview ™ squamous 56 transabdominal 56 Skin Irritation 56 PathFinderTG 56 OvaRex MAb 56 NMIBC 56 interrater 56 Microalbuminuria 56 SELDI TOF 56 prospective multicenter study 56 transcranial Doppler ultrasound 56 bronchoscopic 56 Platelet Function 56 interobserver agreement 56 Atopic Dermatitis 56 NADiA TM 56 N glycan 56 CupPrint 56 PNA FISH TM 56 PI3 kinase inhibitors 56 prognostic indicators 56 scintigraphic 56 AmpliChip 56 Anavex #-# 56 plasma pharmacokinetics 56 T1a 56 immunohistochemistry IHC 56 Microarray analysis 56 Bacteremia 56 Lymphoid 56 Correlative 56 dual endothelin receptor antagonist 56 digital subtraction angiography 56 AtherOx 56 pain palliation 56 Immunohistochemical staining 56 dosimetric 56 histologic subtype 56 cardiac perfusion 56 Multivariate 56 Glomerular filtration rate 56 Electroencephalography 56 Electronic Brachytherapy 56 Protein Expression 56 bladder carcinoma 56 Vitro Diagnostic IVD 56 Adjuvant 56 Integrated Pulmonary 56 HER2 antibody 56 Ocular Surface Disease 56 perfusion imaging 56 MiCK assay 56 Coronary CTA 56 transrectal ultrasound 56 PRECISE 56 Troponin T 56 Aureon 56 Cepheid Xpert 56 immunostaining 56 QPCR 56 convergent validity 55 Angiographic 55 Hemoccult II 55 BACcel ™ 55 Myocardial Perfusion Imaging 55 multimodality imaging 55 prospective multicentre 55 CIN2 + 55 serum thyroglobulin 55 fosbretabulin 55 quantitative PCR 55 vitro assay 55 ELISA kit 55 ABL1 55 MTT assay 55 TIMP 1 55 Degarelix 55 Mutational 55 Crohn Disease Activity 55 hypericin 55 sensitivity specificity 55 stereotactic radiotherapy 55 Intravascular 55 p# biomarker 55 breast cancer subtypes 55 AST ALT 55 Oncotype DX colon cancer 55 fluorodeoxyglucose positron emission tomography 55 liposomal doxorubicin 55 hepatic fibrosis 55 BrachySil TM 55 PressureWire 55 OvPlex 55 myeloperoxidase 55 multivariate Cox 55 metabonomics 55 carotid artery stenting CAS 55 Viatronix V3D Colon 55 AlloMap 55 OvaDx 55 Virtual Histology 55 LungAlert TM 55 stratifying patients 55 Pertuzumab 55 NADiA 55 ASTEROID 55 enterococcal 55 microsatellite instability 55 Galectin 3 55 transcriptomics 55 predictive biomarker 55 pretreatment serum 55 serologic tests 55 PROLARIS 55 gene expression microarray 55 PD2i ® 55 gastrointestinal stromal tumors GISTs 55 prognostic markers 55 clinicopathological features 55 D Dimer 55 HuMax EGFr 55 tissue oxygenation 55 Antisoma AS# 55 TPMT 55 multivariable analysis 55 comparative genomic hybridization 55 Interferon Gamma 55 myocardial necrosis 55 EGS# 55 SELDI TOF MS 55 epoetin alpha 55 cardiac troponin T 55 colorectal liver metastases 55 DHPLC 55 Elastography 55 GeneSearch BLN Assay 55 etiologic 55 gene amplification 55 Dilated Cardiomyopathy 55 Radiographic 55 Toxicogenomics 55 MAGE A3 55 microarray gene expression 55 serological markers 55 radiolabeling 55 Ultrasensitive 55 RRM1 55 Transdermal Delivery 55 CA9 SCAN 55 antiangiogenic agent 55 Solid Tumors 55 Gastrointestinal Stromal Tumors 55 Cytogenetic 55 phase IIIb 55 Virologic 55 skin sterol 55 AF Suppression 55 Alkaline Phosphatase 55 cediranib 55 liver metastasis 55 isoform selective 55 bisulfite sequencing 55 reflux esophagitis 55 SNP rs# [001] 55 Dx TM 55 colonoscopic 55 prognostic significance 55 Helicobacter pylori eradication 55 genomic biomarker 55 colorectal adenoma 55 NGAL 55 MR Angiography 55 proteomic analysis 55 imatinib resistance 55 Pharmacodynamics 55 diagnosing coronary artery 55 Multicenter 55 busulfan 55 Breast Cancer Assay 55 bronchial epithelial cells 55 Resolute stent 55 dyssynchrony 55 miRview mets 55 tumor histology 55 sarcosine 55 BiTE 55 surgically resectable 55 Hematopoietic 54 inhaled AAT 54 Fine needle aspiration 54 preclinical efficacy 54 univariate 54 lymph node biopsies 54 multi analyte 54 genomewide 54 novel immunotherapeutic 54 #F FDG PET CT 54 Histopathologic 54 Analytical Tool 54 BladderChek 54 PITX2 54 Respiratory Virus 54 haematological cancers 54 PREDICTIVE 54 micrometastasis 54 NOD mouse 54 NicAlert 54 florbetaben 54 concurrent chemoradiation 54 RT PCR assay 54 INTRABEAM 54 Papillary 54 lymph node metastasis 54 radioimmunoassay 54 Phenotypic 54 PET tracers 54 interobserver reliability 54 LVNC 54 CYP #D# 54 Squamous 54 cardiac repolarization 54 Phase 1a clinical 54 Contrast Enhanced 54 WT1 54 Optical Coherence Tomography 54 DCE MRI 54 pretest probability 54 Cambridge Heart Microvolt 54 Chemoradiation 54 Fully Covered Stent 54 Immunohistochemistry 54 transrectal ultrasound guided 54 histological diagnosis 54 Sipuleucel T 54 Protelos R 54 Neoplasms 54 Extracellular 54 intraclass correlation coefficient 54 ultrasonographic 54 CINtec ® PLUS 54 YONDELIS R 54 Cervista HPV HR 54 HRCT 54 fluoropyrimidine 54 epididymal 54 Septin 9 54 malignant nodules 54 SSc 54 genes differentially expressed 54 Hematologic 54 multivariate analyzes 54 Clinical Significance 54 Crystalens AO 54 V3D Colon 54 indolent lymphomas 54 Biophysical 54 debulking surgery 54 cytotoxicity assays 54 endoluminal 54 lactate dehydrogenase LDH 54 Antitumor 54 Glycominds 54 miRview ® 54 TaqMan ® 54 HER2 overexpression 54 multiparametric 54 differential gene expression 54 Interferon beta 54 SensoLyte ™ 54 Elevated serum 54 CINtec R 54 Clinical Outcome 54 IIa trials 54 prognostic biomarkers 54 gastric adenocarcinoma 54 Protease Inhibitors 54 annexin 54 colorectal adenocarcinoma 54 multiplex assays 54 miRview ™ mets 54 malignant ascites 54 Hematocrit 54 multivariable Cox 54 Prognostic Value 54 spectrophotometric 54 multicentric 54 Leukocyte 54 tumorigenicity 54 QRT PCR 54 Hemodynamic 54 maternal serum 54 CRMD# 54 albumin excretion rate 54 xenograft mouse 54 D dimer 54 metaplasia 54 procalcitonin 54 urothelial bladder cancer 54 FDG PET CT 54 Mantle Cell Lymphoma 54 electron beam computed tomography 54 indirect immunofluorescence 54 scintigraphy 54 ligand induced 54 quantitative gene expression 54 Placental 54 bronchial hyperresponsiveness 54 PCR assay 54 renal artery stenting 54 intrahepatic cholangiocarcinoma 54 gastric cardia 54 ovarian malignancy 54 Shc 54 ReValving 54 HSCT 54 viral kinetics 54 guaiac 54 waist circumference WC 54 electrophysiologic 54 liposomes containing 54 Intracoronary 54 Prospective Randomized 54 Preclinical Study 54 Pharmacogenomic 54 SUVmax 54 PACCE 54 Alferon N 54 biostatistical analysis 54 colorimetric 54 induced sputum 54 magnetic resonance spectroscopic imaging 54 NMR LipoProfile 54 Sentinel Lymph Node Biopsy 54 SensiGene 54 Motility 54 LungSign TM 54 multicentre randomized 54 prospective longitudinal 54 Hepatocellular Carcinoma 54 percutaneous biopsy 54 Vidaza azacitidine 54 Western blotting 54 transgene expression 54 Roche AmpliChip 54 ECLS 54 sonographic evaluation 54 Nucleic Acid Amplification 54 VitiGam 54 HGD 54 Albuminuria 54 HCT# 54 CK MB 54 Eluting 54 Polymerase Chain Reaction 54 gated SPECT 54 SurroMed 54 humanised antibody 54 cinacalcet 54 HOMA IR 54 tumoral 54 InSure FIT 54 xTAG Cystic Fibrosis 54 adjuvant cisplatin 54 mutated K ras 54 pharmacodynamic parameters 54 Interferon Alfa 54 cardiac magnetic resonance 53 Hybrid Capture 53 pretargeting 53 HDL Selective Delipidation 53 esophageal manometry 53 Clinical Proteomics 53 AlloMap ® 53 Prostate specific antigen 53 neutrophil gelatinase associated lipocalin 53 APPRAISE 53 Cardiac Marker 53 Peripheral Arterial 53 risk reducing salpingo 53 HLA A2 53 BioMAP 53 TRUS 53 BioZ ICG 53 epithelial tumors 53 Initiate Clinical Trial 53 Adenomas 53 MAGE A3 ASCI 53 lesional 53 eTag assays 53 Xpert EV 53 Dacogen decitabine 53 histopathologic examination 53 Safinamide 53 molecular biomarker 53 Analyte 53 nomograms 53 lung metastasis 53 CEACAM1 53 BREVAGen ™ 53 angiographically 53 ankle brachial 53 extracapsular extension 53 Human Leukocyte Antigen 53 B Cell Lymphoma 53 carotid IMT 53 PCA3 assay 53 Cytology 53 MALDI MS 53 multiple logistic regression 53 AdnaTest 53 OnDose 53 Transcranial 53 Angiolix 53 antigen PSA levels 53 Seeplex 53 LRP5 53 pharmacodynamic markers 53 RE LY trial 53 abacavir Ziagen 53 Cystatin C 53 β blockers 53 PathVysion 53 airway hyperresponsiveness 53 multimodality therapy 53 Polymorphism 53 Aethlon Hemopurifier R 53 cervical cytology 53 PLAC Test 53 Annexin V 53 SAXS 53 Olmesartan 53 PCA3 gene 53 AxSYM 53 Onko Sure TM 53 visceral adiposity 53 troponin assay 53 Proliferative 53 EGFR receptor 53 MGd 53 Microarray Analysis 53 mSEPT9 53 Dendritic cell 53 UV Visible 53 prognostic indicator 53 murine model 53 Ultrasonographic 53 biliary tract cancer 53 Tomographic 53 transthoracic echocardiography 53 Endometrial 53 QTL mapping 53 Dendritic Cells 53 Renal Artery 53 PEGylated interferon 53 leiomyomas 53 tissue transglutaminase 53 NRTI resistance 53 Epithelium 53 ActiPix 53 Electrodiagnostic 53 Prognostic factors 53 aminotransferase ALT 53 Left Ventricular 53 myocardial viability 53 postoperative radiotherapy 53 Onko Sure ® 53 Squalamine 53 LUMINATE 53 PHPT 53 SYNTAX 53 lymphoid malignancies 53 pancreatic ductal 53 pharmacokinetic PK 53 immunohistochemical staining 53 E. faecalis 53 Mutation Analysis 53 oncologic outcomes 53 EUS FNA 53 Serologic 53 Patency 53 histologically confirmed 53 oncological outcomes 53 DCVax R 53 enzyme kinetics 53 prognostic marker 53 neratinib 53 autologous SCT 53 locoregional recurrence 53 Telomere 53 mucinous 53 DNA methylation biomarker 53 promoter methylation 53 Transcriptome 53 PEG IFN 53 Spectrometry 53 Myocardial Ischemia 53 Contrast Agents 53 kinase inhibition 53 EGIR 53 idiopathic myelofibrosis 53 QuadraSphere 53 PD2i Analyzer 53 Carotid Artery Stenting 53 MammaPrint 53 p tau 53 Mucosal 53 seropositivity 53 proteomic biomarkers 53 cytological 53 Pemetrexed 53 ascending aortic 53 preterm neonates 53 DermaVir Patch 53 EQ 5D 53 ChIP chip 53 glycopeptides 53 Leydig cell 53 NOD SCID mice 53 PRESEPT study 53 gastroesophageal cancer 53 gefitinib Iressa 53 pharmacodynamic PD 53 Spectral EAA TM 53 microvessel density 53 Breast Tissue 53 diagnostic prognostic 53 Lupus Erythematosus 53 Microdosing 53 laparoscopic radical nephrectomy 53 Adjuvant Therapy 53 ALSFRS R 53 Avise PG 53 serum lactate 53 ChemoFx ® 53 Microsatellite 53 extramedullary 53 localized renal 53 papillary thyroid carcinoma 53 PCR RFLP 53 adenoma recurrence 53 Skin sterol 53 Carotid endarterectomy 53 Bayesian inference 53 Zybrestat 53 adenomatous 53 Tr DNA 53 bFGF 53 colon capsule endoscopy 53 SYNTAX trial 53 ABRF 53 pharmaco 53 Diagnostic Tests 53 Tc#m 53 PRESEPT 53 Carotid Endarterectomy 53 protein biomarker 53 tumor perfusion 53 Fc gamma receptor 53 transient elastography 53 Ion Trap 53 CLIRS 53 Vizilite 53 tumor necrosis 53 IRX 53 enzyme immunoassay EIA 53 Figure 1A 53 cytokeratin 53 AttoSense 53 GSTP1 53 thymoma 53 heparanase 53 LHRH receptor positive 53 EuroSCORE 53 extracranial 53 antibiotic susceptibility 53 p# inhibitor 53 HLA DQ2 53 urodynamic parameters 53 hemodynamic variables 53 prospectively enrolled 53 Prostatic 53 Personalized Chemotherapy 53 Digital Mammographic Imaging 53 thyroid peroxidase 53 Dosimetry 53 transcranial Doppler 53 quantitative RT PCR 53 microRNA expression 53 Aurora Kinase 53 medically inoperable 53 computed tomographic 53 Left Ventricular Dysfunction 53 multivariate regression analysis 53 Contrast Agent 53 EURIDIS 53 histologic diagnosis 53 isoprostanes 53 total thyroidectomy 53 hematological parameters 53 ERalpha 53 grade squamous intraepithelial 53 humoral responses 53 KRAS BRAF 53 metastatic lymph nodes 53 preoperative diagnosis 53 Molecular Diagnostic 53 ADAMTS# 53 Array CGH 53 Sanvar 53 PFO migraine 53 Moderate Complexity 53 somatostatin analog 53 hepatic lesions 53 Cervista HPV 53 periprocedural MI 53 ISAR TEST 53 histologically proven 53 TSQ Quantum 53 gene expression microarrays 53 novel oral anticoagulant 53 Prostate Px + 53 NPM1 53 Abbott ARCHITECT 53 cervical lymph node 53 Diazyme 53 ADVIA Centaur 53 Agilent #B [002] 52 demyelinating 52 BeadXpress 52 Saclay France 52 Cannabinoid 52 Randomized Study 52 Tumor Response 52 Prolongs Survival 52 Enzyme Linked 52 adjuvant trastuzumab 52 percutaneous vertebroplasty 52 potent inducer 52 multicenter randomized controlled 52 cytogenic 52 Kinase Inhibitors 52 Thrombolysis 52 thalidomide Thalomid 52 Assay Kits 52 multicenter clinical trials 52 Immunohistochemistry IHC 52 EBUS FNA 52 binary logistic regression 52 intraclass correlation coefficients 52 ResponseDX Colon TM 52 metastatic neuroendocrine tumors 52 conditional logistic regression 52 PCR Polymerase Chain Reaction 52 Monocytes 52 PLAC test 52 multivariable analyzes 52 morphologic characteristics 52 VBLOC RF2 52 Cardiorespiratory fitness 52 Rubicon Filter 52 transvaginal sonography 52 Interferon Beta 52 vitro cytotoxicity 52 photoprotective drug 52 β1 52 demonstrated clinically meaningful 52 radionuclide imaging 52 myocardial infarct size 52 SELENA SLEDAI 52 fluorescence polarization 52 JAK Inhibitor 52 AFRS TM 52 hormone receptor status 52 Hemospan 52 PROPATEN Bioactive Surface 52 uricase 52 NSABP B 52 Orally Active 52 Liquid chromatography 52 Tyrosine Kinase Inhibitor 52 Anticancer Drug 52 Main Outcome Measure 52 HER2 amplification 52 Diamondback #deg 52 kinase assay 52 TMPRSS2 ERG fusion 52 degranulation 52 Reperfusion 52 Haptoglobin 52 immunoblotting 52 StemEx R 52 ionization mass spectrometry 52 nonmetastatic 52 NuroPro ® 52 MGMT methylation 52 laser microdissection 52 Allogeneic 52 Cancer Vaccines 52 Lenalidomide 52 gadolinium enhanced 52 biomarker assay 52 EpCAM 52 Oncotype DX breast cancer 52 x ray angiography 52 Bioavailability 52 HPV genotyping 52 Hepatic 52 surgically resected 52 #F FDG 52 quantitate 52 logistic regression analyzes 52 PhenoSense GT 52 ELISA enzyme 52 AZILECT ® 52 chemiluminescence 52 throughput RNAi 52 gastrointestinal stromal tumors GIST 52 Benign Prostatic Hyperplasia 52 non resectable metastatic 52 putative biomarkers 52 HGPIN 52 ADVIA 52 electrospray ionisation 52 radiation dosimetry 52 Orazol 52 Cardiac Resynchronization Therapy 52 serum biomarkers 52 Multimodality 52 S. maltophilia 52 qNPA 52 multicenter Phase II 52 Medicsight ColonCAD 52 Inactivation 52 xCELLigence System 52 ALA PDT 52 Zarnestra 52 steroidogenesis 52 Onconase 52 PROactive study 52 transrectal ultrasonography 52 MDRD 52 ResponseDX ™ 52 urothelial 52 folate receptor 52 Immunogenicity 52 specific IgE 52 VeraTag 52 CD# expression [001] 52 CINQUIL 52 pancreatic adenocarcinoma 52 Mesothelin 52 Randomised 52 cerebral oximetry 52 plasma renin activity 52 echocardiographic parameters 52 automated immunoassay 52 multivariable logistic regression 52 low expressors 52 arteriography 52 Legg Calvé Perthes disease 52 C Reactive Protein 52 Collategene 52 urodynamic 52 antithrombotic agents 52 Lipoprotein 52 Antiviral Activity 52 radionuclide therapy 52 Acute Ischemic Stroke 52 Extracellular Matrix 52 LAB CGRP 52 extrapleural pneumonectomy 52 immunofluorescence 52 AGHD 52 intraepithelial neoplasia 52 Cytotoxicity 52 metabolite identification 52 radiosensitivity 52 Hepatotoxicity 52 Mortality Risk 52 Anticalins ® 52 linkage disequilibrium LD 52 serum estradiol 52 HIF 1a 52 renal cortical 52 ZACTIMA 52 beta lactams 52 pharmacokinetic PK study 52 Histone 52 Hexvix ® 52 somatostatin analogues 52 ovarian pancreatic 52 Afib 52 Toxicological 52 Cytochrome P# 52 positron emission topography 52 humanized monoclonal 52 proton MR spectroscopy 52 IGFBP2 52 HyACT 52 kinase profiling 52 phenotyping 52 metastatic gastric 52 Isotopic 52 alpha1 antitrypsin deficiency 52 genetic biomarkers 52 contrast echocardiography 52 Stage IIB 52 GAMMAGARD 52 plasma cortisol 52 Nucleic Acids 52 noninvasive imaging 52 FFR measurements 52 P#Y# [002] 52 Antitumor Activity 52 Radionuclide 52 carotid stenosis 52 interstitial brachytherapy 52 adjuvant radiotherapy 52 FDG uptake 52 mg/m2 cohort 52 BRCA mutation carriers 52 pCR 52 thyroid nodules 52 NKX#.# 52 Modrenal 52 teratogenicity 52 experimentally validated 52 #S rRNA gene 52 Randomized Evaluation 52 PreDx DRS 52 Pulmotype 52 intralesional 52 Hsp# Inhibitor 52 PLCO 52 ILLUSTRATE 52 Optical coherence tomography 52 BACcel